最新报道:Baird downgraded UnitedHealth Group shares to "neutral" from "outperform," citing growing concerns over the company's Optum health services division. Analyst Whit Mayo highlighted slowing growth in Optum's pharmacy benefit management and care delivery segments, along with regulatory scrutiny on its $3.3 billion acquisition of Amedisys. The downgrade comes as UnitedHealth faces margin pressures across its businesses, with Mayo cutting the price target to $550 from $610. Shares fell 2.5% following the report, underperforming the broader healthcare sector. The firm remains one of Wall Street's most widely held healthcare stocks despite recent challenges.